393 related articles for article (PubMed ID: 19465707)
21. Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection.
Dervisevic S; Pillay D
J HIV Ther; 2003 Nov; 8(4):89-95. PubMed ID: 14671506
[TBL] [Abstract][Full Text] [Related]
22. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
23. Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy?
Jain MK; Opio CK; Osuagwu CC; Pillai R; Keiser P; Lee WM
Clin Infect Dis; 2007 Apr; 44(7):996-1000. PubMed ID: 17342656
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of chronic hepatitis B in HIV co-infected patients].
Massard J; Benhamou Y
Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt 2):S20-4. PubMed ID: 18662606
[TBL] [Abstract][Full Text] [Related]
25. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
[TBL] [Abstract][Full Text] [Related]
26. Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection.
Nüesch R; Ananworanich J; Srasuebkul P; Chetchotisakd P; Prasithsirikul W; Klinbuayam W; Mahanontharit A; Jupimai T; Ruxrungtham K; Hirschel B
AIDS; 2008 Jan; 22(1):152-4. PubMed ID: 18090405
[TBL] [Abstract][Full Text] [Related]
27. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
Cheruvu S; Marks K; Talal AH
Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
[TBL] [Abstract][Full Text] [Related]
28. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
Hofmann WP; Soriano V; Zeuzem S
Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
[TBL] [Abstract][Full Text] [Related]
29. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.
Chang JJ; Wightman F; Bartholomeusz A; Ayres A; Kent SJ; Sasadeusz J; Lewin SR
J Virol; 2005 Mar; 79(5):3038-51. PubMed ID: 15709024
[TBL] [Abstract][Full Text] [Related]
30. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
31. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
Soriano V; Puoti M; Peters M; Benhamou Y; Sulkowski M; Zoulim F; Mauss S; Rockstroh J
AIDS; 2008 Jul; 22(12):1399-410. PubMed ID: 18614862
[TBL] [Abstract][Full Text] [Related]
32. Current treatment of HIV/hepatitis B virus coinfection.
Iser DM; Sasadeusz JJ
J Gastroenterol Hepatol; 2008 May; 23(5):699-706. PubMed ID: 18410604
[TBL] [Abstract][Full Text] [Related]
33. Management of chronic hepatitis B and C in HIV-coinfected patients.
Soriano V; Barreiro P; Nuñez M
J Antimicrob Chemother; 2006 May; 57(5):815-8. PubMed ID: 16556638
[TBL] [Abstract][Full Text] [Related]
34. Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
Gutiérrez S; Guillemi S; Jahnke N; Montessori V; Harrigan PR; Montaner JS
Clin Infect Dis; 2008 Feb; 46(3):e28-30. PubMed ID: 18181733
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy.
Chauvel O; Lacombe K; Bonnard P; Lascoux-Combe C; Molina JM; Miailhes P; Girard PM; Carrat F
Antivir Ther; 2007; 12(7):1115-26. PubMed ID: 18018770
[TBL] [Abstract][Full Text] [Related]
36. Treatment of HBV-related cirrhosis.
Vallet-Pichard A; Mallet V; Costentin CE; Pol S
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
Chu CJ; Lee SD
J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482
[TBL] [Abstract][Full Text] [Related]
38. Case report. Hepatitis B virus and HIV coinfection.
Piliero PJ; Faragon JJ
AIDS Read; 2002 Oct; 12(10):443-4, 448-51. PubMed ID: 12408101
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and management of hepatitis B virus and HIV coinfection.
Peters MG
Top HIV Med; 2007; 15(5):163-6. PubMed ID: 18073452
[TBL] [Abstract][Full Text] [Related]
40. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection.
Lascar RM; Gilson RJ; Lopes AR; Bertoletti A; Maini MK
J Infect Dis; 2003 Dec; 188(12):1815-9. PubMed ID: 14673759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
